Merck KGaA’s lupus drug to advance to Phase III despite mixed data
While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary endpoint.
ATS 2025: promising results with gremubamab in bronchiectasis
AnnJi reports outcomes from trial of spinal bulbar muscular atrophy therapy
Accropeutics’ TYK2/JAK1 inhibitor meets endpoints in Phase II psoriasis trial
WHO Pandemic Agreement will prevent and control disease outbreaks
Queen’s Health Sciences launches support unit for trials
Analysis
View More
Themes
View MorePharma’s AI prospects get nudged into the future with EU’s AI act
Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment
IoT can help to reduce the burden of clinical trials on patients
Mastering compliance and copyright in healthcare and MedComms